Ownership and insider activity for IDEXX Laboratories, Inc. (IDXX): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors.
Price
| Price | $527.07 |
| Market Cap | $41.6B |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-04 | Kingsley Lawrence D | M-Exempt | 2,203 | $252K |
| 2026-09-04 | Kingsley Lawrence D | S-Sale | 2,203 | $1.2M |
| 2026-09-04 | Kingsley Lawrence D | M-Exempt | 2,203 | $252K |
| 2026-08-20 | Emerson Andrew | M-Exempt | 265 | $47K |
| 2026-08-20 | Emerson Andrew | F-InKind | 86 | |
| 2026-08-20 | Emerson Andrew | M-Exempt | 265 | $47K |
| 2026-07-30 | HOOLEY JOSEPH L | A-Award | 49 | $27K |
| 2026-06-01 | FENNELL GEORGE | M-Exempt | 639 | |
| 2026-06-01 | FENNELL GEORGE | F-InKind | 284 | $161K |
| 2026-06-01 | FENNELL GEORGE | M-Exempt | 639 |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $154.9M | $187.7M | $123.8M | $90.3M | $383.9M | $144.5M | $112.5M | $453.9M | $288.3M | $180.1M |
| Short-term Investments | $236.9M | $284.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $232.2M | $270.1M | $258.5M | $307.5M | $374.7M | $425.6M | $490.9M | $529.5M | $561.3M | $693.2M |
| Inventory | $158.0M | $164.3M | $173.3M | $195.0M | $209.9M | $269.0M | $367.8M | $380.3M | $381.9M | $377.8M |
| Total Current Assets | $845.6M | $972.0M | $654.2M | $679.6M | $1.06B | $955.7M | $1.10B | $1.50B | $1.40B | $1.34B |
| Property, Plant & Equipment | $357.4M | $379.1M | $437.3M | $614.5M | $646.3M | $692.8M | $768.1M | $817.7M | $829.3M | $870.6M |
| Goodwill | $178.2M | $199.9M | $214.5M | $239.7M | $243.3M | $359.3M | $361.8M | $366.0M | $405.1M | $414.0M |
| Intangible Assets | $46.2M | $43.8M | $41.8M | $58.5M | $52.5M | $99.0M | $97.7M | $84.5M | $111.7M | $109.8M |
| Total Assets | $1.53B | $1.71B | $1.54B | $1.83B | $2.29B | $2.44B | $2.75B | $3.26B | $3.29B | $3.35B |
| Accounts Payable | $60.1M | $67.0M | $69.5M | $72.2M | $74.6M | $116.1M | $110.2M | $110.6M | $114.2M | $110.4M |
| Short-term Debt | $611.0M | $655.0M | $398.9M | $288.8M | $50.0M | $148.5M | $654.0M | $325.0M | $417.8M | $500.1M |
| Total Current Liabilities | $934.6M | $1.00B | $770.4M | $725.3M | $582.8M | $763.6M | $1.24B | $951.5M | $1.07B | $1.15B |
| Long-term Debt | $593.1M | $606.1M | $601.3M | $698.9M | $858.5M | $775.2M | $694.4M | $622.9M | $449.8M | $476.0M |
| Total Liabilities | $1.64B | $1.77B | $1.55B | $1.65B | $1.66B | $1.75B | $2.14B | $1.78B | $1.70B | $1.75B |
| Retained Earnings | $540.4M | $803.5M | $1.17B | $1.60B | $2.18B | $2.92B | $3.60B | $4.44B | $5.33B | $6.39B |
| Total Equity | -$108.4M | -$54.1M | -$9.5M | $177.5M | $632.1M | $690.0M | $608.7M | $1.48B | $1.60B | $1.61B |
| Total Debt | $1.20B | $1.26B | $1.00B | $1.07B | $1.00B | $1.03B | $1.47B | $1.07B | $986.9M | $1.08B |
| Net Debt | $812.3M | $789.1M | $876.5M | $980.1M | $619.3M | $886.6M | $1.36B | $613.4M | $698.7M | $897.1M |
| Working Capital | -$89.0M | -$32.6M | -$116.3M | -$45.7M | $480.0M | $192.1M | -$134.3M | $543.7M | $332.0M | $191.4M |
Financial Health
| Debt / Equity | 0.68 |
| Current Ratio | 1.17 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 23.99 |
Profitability
| Return on Equity | 71.96% |
| Return on Invested Capital | 40.94% |
| Return on Assets | 33.11% |
| Gross Margin | 62.45% |
| Operating Margin | 32.03% |
| Net Margin | 25.03% |
Related companies: A · ALNY · ARGX · BDX · CAH · COR · EW
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of IDXX: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks